APPLICATION OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHY IN THERAPEUTIC DRUG LEVEL MONITORINGSADEE W.1980; ACTA PHARM. TECHNOL.; DEU; DA. 1980; VOL. 26; NO 1; PP. 1-11; ABS. GER; BIBL. 104 REF.Article

ANTINEOPLASTIC AGENTS: HIGH-DOSE METHOTREXATE AND CITROVORUM FACTOR RESCUESADEE W.1980; THER. DRUG MONIT.; USA; DA. 1980; VOL. 2; NO 2; PP. 177-185; BIBL. 48 REF.Article

Genomics and drugs : Finding the optimal drug for the right patientSADEE, W.Pharmaceutical research. 1998, Vol 15, Num 7, pp 959-963, issn 0724-8741Article

Protein drugs: a revolution in therapy?SADEE, W.Pharmaceutical research. 1986, Vol 3, Num 1, pp 3-4, issn 0724-8741Article

5-FLUOROURACIL CONCENTRATIONS IN HUMAN PLASMA FOLLOWING R,S-1-(TETRAHYDRO-2-FURANYL)-5-FLUOROURACIL (FTORAFUR) ADMINISTRATIONAU JL; SADEE W.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 10; PP. 4289-4290; BIBL. 13 REF.Article

METHOTREXATE AND 7-HYDROXYMETHOTREXATE: SERUM LEVEL MONITORING BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHYCANFELL C; SADEE W.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 1; PP. 165-169; BIBL. 9 REF.Article

CONTRIBUTIONS OF THE DEPLETIONS OF GUANINE AND ADENINE NUCLEOTIDES TO THE TOXICITY OF PURINE STARVATION IN THE MOUSE T LYMPHOMA CELL LINE = CONTRIBUTIONS DE LA DIMINUTION DES ADENINE ET GUANINE NUCLEOTIDES A LA TOXICITE DUE A LA PRIVATION DE PURINES DANS LA LIGNEE CELLULAIRE DU LYMPHOME T CHEZ LA SOURISCOHEN MB; SADEE W.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 4; PP. 1587-1591; ABS. ENG; BIBL. 28 REF.; GRAPH.Article

HYDROXYLATED METABOLITES OF R,S-1(TETRAHYDRO-2-FURANYL)-5-FLUOROURACIL (FTORAFUR) IN RATS AND RABBITS.WU AT; AU JL; SADEE W et al.1978; CANCER RES.; U.S.A.; DA. 1978; VOL. 38; NO 1; PP. 210-214; BIBL. 19 REF.Article

Genes and the pharmaceutical sciencesSADEE, W.Pharmaceutical research. 1988, Vol 5, Num 4, pp 199-200, issn 0724-8741Article

DETERMINATION OF 5-FLUOROURACIL (NSC-19893) PLASMA LEVELS IN RATS AND MAN BY ISOTOPE DILUTION-MASS FRAGMENTOGRAPHYFINN C; SADEE W.1975; CANCER CHEMOTHERAPY REP.; U.S.A.; DA. 1975; VOL. 59; NO 2; PP. 279-286; BIBL. 15REF.Article

ACTIVATION OF FTORAFUR (R,S-1-(TETRAHYDRO-2-FURANYL)-5-FLUOROURACIL) TO 5-FLUOROURACIL AND GAMMA -BUTYROLACTONELAI SIM AU J; SADEE W.1980; CANCER RES.; ISSN 0008-5472; USA; DA. 1980; VOL. 40; NO 8; PP. 2814-2819; BIBL. 27 REF.Article

TISSUE DISTRIBUTION OF ³H-CANRENOATE POTASSIUM IN RABBITS.FINN AM; BROWN R; SADEE W et al.1977; J. PHARM. SCI.; U.S.A.; DA. 1977; VOL. 66; NO 2; PP. 275-277; BIBL. 9 REF.Article

MECHANISM OF THE REACTION OF A 1,4-BENZODIAZEPINE N-OXIDE WITH ACETIC ANHYDRIDECASTAGNOLI N JR; SADEE W.1972; J. MEDICIN. CHEM.; U.S.A.; DA. 1972; VOL. 15; NO 10; PP. 1076-1078; BIBL. 11 REF.Serial Issue

IN VIVO RATES OF PYRIMIDINE NUCLEOTIDE METABOLISM IN INTACT MOUSE T-LYMPHOMA (S-49) CELLS TREATED WITH 5-FLUOROURACILMAYBAUM J; COHEN MB; SADEE W et al.1981; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1981; VOL. 256; NO 5; PP. 2126-2130; BIBL. 26 REF.Article

PHARMACOKINETICS AND METABOLISM OF FTORAFUR IN MANAU JL; WU AT; FRIEDMAN MA et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 3; PP. 343-350; BIBL. 20 REF.Article

DETERMINATION OF FTORAFUR AND 5-FLUOROURACIL LEVELS IN PLASMA AND URINE.WU AT; SCHWANDT HJ; FINN C et al.1976; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; U.S.A.; DA. 1976; VOL. 14; NO 1; PP. 89-102; BIBL. 1 P.Article

ALDOSTERONE PLASMA RADIOIMMUNOASSAY INTERFERENCE BY A SPIROLACTONE METABOLITE = INTERFERENCE D'UN METABOLITE DE LA SPIROLACTONE DANS LE DOSAGE RADIOIMMUNOLOGIQUE DE L'ALDOSTERONE PLASMATIQUESADEE W; FINN AM; SCHMIEDEK P et al.1975; STEROIDS; U.S.A.; DA. 1975; VOL. 25; NO 3; PP. 301-311; BIBL. 1PArticle

GUANINE NUCLEOTIDE DEPLETION AND TOXICITY IN MOUSE T LYMPHOMA (S-49) CELLSCOHEN MB; MAYBAUM J; SADEE W et al.1981; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1981; VOL. 256; NO 16; PP. 8713-8717; BIBL. 19 REF.Article

METABOLIC REARRANGEMENTS OF 1,4-BENZODIAZEPINE DERIVATIVESSCHWANDT HJ; SADEE W; BEYER KH et al.1974; XENOBIOTICA; G.B.; DA. 1974; VOL. 4; NO 12; PP. 733-741; BIBL. 17REF.Article

BUPRENORPHINE: DIFFERENTIAL INTERACTION WITH OPIATE RECEPTOR SUBTYPES IN VIVOSADEE W; ROSENBAUM JS; HERZ A et al.1982; JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS; ISSN 0022-3565; USA; DA. 1982; VOL. 223; NO 1; PP. 157-162; BIBL. 22 REF.Article

DETERMINATION OF PYRIMIDINE RIBOTIDE AND DEOXYRIBOTIDE POOLS IN CULTURED CELLS AND MOUSE LIVER BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHYMAYBAUM J; KLEIN FK; SADEE W et al.1980; J. CHROMATOGR.; NLD; DA. 1980; VOL. 188; NO 1; PP. 149-158; BIBL. 12 REF.Article

DETERMINATION OF URACIL AND THYMINE AND THEIR NUCLEOSIDES AND NUCLEOTIDES IN PICOMOLE AMOUNTS BY GAS CHROMATOGRAPHY MASS SPECTROMETRY SELECTED ION MONITORINGFINN C; SCHWANDT HJ; SADEE W et al.1979; BIOMED. MASS SPECTROM.; GBR; DA. 1979; VOL. 6; NO 5; PP. 194-199; BIBL. 28 REF.Article

SYNTHESIS OF 5-AZACYTIDINE 6-¹³C AND 6-¹⁴C.CHAN KK; STAROSCIK JA; SADEE W et al.1977; J. MEDICIN. CHEM.; U.S.A.; DA. 1977; VOL. 20; NO 4; PP. 598-600; BIBL. 13 REF.Article

In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the ratRICHARDS, M. L; SADEE, W.The Journal of pharmacology and experimental therapeutics. 1985, Vol 233, Num 2, pp 425-432, issn 0022-3565Article

(³H) ETORPHINE RECEPTOR BINDING IN VIVO: SMALL FRACTIONAL OCCUPANCY ELICITS ANALGESIAPERRY DC; ROSENBAUM JS; KUROWSKI M et al.1982; MOL. PHARMACOL.; ISSN 0026-895X; USA; DA. 1982; VOL. 21; NO 2; PP. 272-279; BIBL. 29 REF.Article